Watch stocks you care about
The single, easiest way to keep track of all the stocks that matter...
Your own personalized stock watchlist!
It's a 100% FREE Motley Fool service...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of medical-device maker Mindray Medical (NYSE: MR ) were feeling ill today, down by as much as 14%, after the company reported quarterly earnings results last night.
So what: Third-quarter revenue added up to $218.4 million, while earnings per share were $0.36. Both figures topped the market expectations of $197.9 in sales and $0.33 in earnings per share, so it's unclear what disappointed investors today.
Now what: To top it off, the company has also authorized a $100 million share-buyback program. All segments posted healthy double-digit growth across the board, with the Medical Imaging Systems segment growing the slowest at 24.5%. Following the results, Nomura Securities has reiterated its Buy rating on Mindray Medical with a $34 price target, citing stronger sales growth.
Interested in more info on Mindray Medical? Add it to your watchlist.